Recent advances in the basic science of chondrosarcoma

Orthopedic Clinics of North America

Volumn 37, Issue 1, 2006, Pages 9-14

  Terek, Richard M ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER GROWTH; CANCER SCREENING; CANCER THERAPY; CHONDROSARCOMA; CHROMOSOME ANALYSIS; CYTOGENETICS; DRUG RESPONSE; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION; GENE FUNCTION; HUMAN; METASTASIS; MOLECULAR DYNAMICS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

APOPTOSIS; BONE NEOPLASMS; CHONDROSARCOMA; CYTOGENETICS; FEMALE; FORECASTING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MOLECULAR BIOLOGY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RISK ASSESSMENT; RNA-BINDING PROTEINS;

EID: 28344457690     PISSN: 00305898     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ocl.2005.09.001     Document Type: Review

References (46)

1. J.V. Bovee, A.M. Cleton-Jansen, and A.H. Taminiau Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment Lancet Oncol 6 8 2005 599 607
2. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 1 2000 57 70
3. A.A. Sandberg Genetics of chondrosarcoma and related tumors Curr Opin Oncol 16 4 2004 342 354
4. A.A. Sandberg, and J.A. Bridge Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms Cancer Genet Cytogenet 143 1 2003 1 31
5. C. Francannet, A. Cohen-Tanugi, and M. Le Merrer Genotype-phenotype correlation in hereditary multiple exostoses J Med Genet 38 7 2001 430 434
6. D.E. Porter, L. Lonie, and M. Fraser Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study J Bone Joint Surg [Br] 86 7 2004 1041 1046
7. S. Hopyan, N. Gokgoz, and R. Poon A mutant PTH/PTHrP type I receptor in enchondromatosis Nat Genet 30 3 2002 306 310
8. S. Hopyan, P. Nadesan, and C. Yu Dysregulation of hedgehog signalling predisposes to synovial chondromatosis J Pathol 206 2 2005 143 150
9. T.D. Tiet, and B.A. Alman Developmental pathways in musculoskeletal neoplasia: involvement of the Indian Hedgehog-parathyroid hormone-related protein pathway Pediatr Res 53 4 2003 539 543
10. H.M. van Beerendonk, L.B. Rozeman, and A.H. Taminiau Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression J Pathol 202 3 2004 359 366
11. J. Asp, L. Sangiorgi, and S.E. Inerot Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues Int J Cancer 85 6 2000 782 786
12. N. Ferrara, and T. Davis-Smyth The biology of vascular endothelial growth factor Endocr Rev 18 1 1997 4 25
13. R.M. Terek, J.H. Healey, and P. Garin-Chesa p53 mutations in chondrosarcoma Diagn Mol Pathol 7 1 1998 51 56
14. M. Amling, M. Posl, and M.W. Hentz PTHrP and Bcl-2: essential regulatory molecules in chondrocyte differentiation and chondrogenic tumors Verh Dtsch Ges Pathol 82 1998 160 169
15. J.V. Bovee, L.J. van Den Broek, and A.M. Cleton-Jansen Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma Lab Invest 80 12 2000 1925 1934
16. T. Miyaji, T. Nakase, and E. Onuma Monoclonal antibody to parathyroid hormone-related protein induces differentiation and apoptosis of chondrosarcoma cells Cancer Lett 199 2 2003 147 155
17. J.V. Bovee, L.J. van Den Broek, and A.M. Cleton-Jansen Chondrosarcoma is not characterized by detectable telomerase activity J Pathol 193 3 2001 354 360
18. E.K. Rofstad Microenvironment-induced cancer metastasis Int J Radiat Biol 76 5 2000 589 605
19. J.A. Martin, B.R. DeYoung, and S. Gitelis Telomerase reverse transcriptase subunit expression is associated with chondrosarcoma malignancy Clin Orthop Relat Res 426 2004 117 124
20. R.S. Kerbel Tumor angiogenesis: past, present and the near future Carcinogenesis 21 3 2000 505 515
21. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 3 1996 353 364
22. N. Weidner, J.P. Semple, and W.R. Welch Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma N Engl J Med 324 1 1991 1 8
23. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 21 1971 1182 1186
24. J. Folkman Fighting cancer by attacking its blood supply Sci Am 275 3 1996 150 154
25. R.L. McGough, B.I. Aswad, and R.M. Terek Pathologic neovascularization in cartilage tumors Clin Orthop 397 2002 76 82
26. P.H. Maxwell, C.W. Pugh, and P.J. Ratcliffe Activation of the HIF pathway in cancer Curr Opin Genet Dev 11 3 2001 293 299
27. R.L. McGough, C. Lin, and P. Meitner Angiogenic cytokines in cartilage tumors Clin Orthop Relat Res 397 2002 62 69
28. C. Lin, R. McGough, and B. Aswad Hypoxia induces HIF-1alpha and VEGF expression in chondrosarcoma cells and chondrocytes J Orthop Res 22 6 2004 1175 1181
29. J. Fang, L. Yan, and Y. Shing HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumor genesis Cancer Res 61 15 2001 5731 5735
30. H. Brem, and J. Folkman Inhibition of tumor angiogenesis mediated by cartilage J Exp Med 141 2 1975 427 439
31. Y. Hiraki, K. Mitsui, and N. Endo Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cells Eur J Biochem 260 3 1999 869 878
32. M.A. Moses, D. Wiederschain, and I. Wu Troponin I is present in human cartilage and inhibits angiogenesis Proc Natl Acad Sci USA 96 6 1999 2645 2650
33. L. Weissbach, and B.V. Treadwell A plasminogen-related gene is expressed in cancer cells Biochem Biophys Res Commun 186 2 1992 1108 1114
34. Y. Hiraki, and C. Shukunami Chondromodulin-I as a novel cartilage-specific growth-modulating factor Pediatr Nephrol 14 7 2000 602 605
35. Y. Hiraki, K. Mitsui, and N. Endo Molecular cloning of human chondromodulin-I, a cartilage-derived growth modulating factor, and its expression in Chinese hamster ovary cells Eur J Biochem 260 3 1999 869 878
36. H. Morioka, L. Weissbach, and T. Vogel Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis Clin Cancer Res 9 3 2003 1211 1217
37. K.R. Berend, A.P. Toth, and J.M. Harrelson Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma J Bone Joint Surg [Am] 80 1 1998 11 17
38. J. Yuan, C.M. Dutton, and S.P. Scully RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion J Orthop Res 2005 in press
39. X. Jiang, C.M. Dutton, and W. Qi Inhibition of MMP-1 expression by antisense RNA decreases invasiveness of human chondrosarcoma J Orthop Res 21 6 2003 1063 1070
40. X. Jiang, C.M. Dutton, and W.N. Qi siRNA mediated inhibition of MMP-1 reduces invasive potential of a human chondrosarcoma cell line J Cell Physiol 202 3 2005 723 730
41. D.W. Seo, H. Li, and L. Guedez TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism Cell 114 2 2003 171 180
42. W.W. Spurbeck, C.Y. Ng, and E.F. Vanin Retroviral vector-producer cell-mediated in vivo gene transfer of TIMP-3 restricts angiogenesis and neuroblastoma growth in mice Cancer Gene Ther 10 3 2003 161 167
43. R.M. Terek, G.K. Schwartz, and K. Devaney Chemotherapy and P-glycoprotein expression in chondrosarcoma J Orthop Res 16 5 1998 585 590
44. J.J. Wyman, A.M. Hornstein, and P.A. Meitner Multidrug resistance-1 and p-glycoprotein in human chondrosarcoma cell lines: expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance J Orthop Res 17 6 1999 935 940
45. R.N. Rosier, R.J. O'Keefe, and L.A. Teot P-glycoprotein expression in cartilaginous tumors J Surg Oncol 65 2 1997 95 105
46. L. Shao, J. Kasanov, and F.J. Hornicek Ecteinascidin-743 drug resistance in sarcoma cells: transcriptional and cellular alterations Biochem Pharmacol 66 12 2003 2381 2395